Nir Barzilai

Nir Barzilai, M.D., the Director of the Institute for Aging Research at Albert Einstein College of Medicine, shares groundbreaking insights about longevity. He reveals genetic clues from centenarians, discussing how specific gene variants contribute to long lifespans. The conversation explores the TAME trial, emphasizing the potential of metformin as a longevity tool and its varied impacts on health. Barzilai also touches on epigenetic clocks and the controversial role of NAD precursors in aging, inviting listeners to reconsider their understanding of what it means to live a longer, healthier life.

Dr. Nir Barzilai, a leading geroscientist and professor at Albert Einstein College of Medicine, dives into the fascinating world of aging research. He discusses the groundbreaking potential of metformin to not only manage diabetes but also to delay aging. The conversation also touches on insights from centenarians, the impact of genetics on longevity, and the role of the microbiome. Barzilai shares his pioneering work with the TAME trial, aiming to convince the FDA that aging can be treated, transforming our understanding of healthspan and lifespan.

Explore the pursuit of longevity from ancient myths to modern scientific advancements like young blood transfusions and NAD supplements. Delve into the effects of young blood on aging and the debate around longevity supplements. Discover the potential of NAD boosters and Metformin for anti-aging benefits. Learn about upcoming episodes on fasting and the importance of lifestyle factors for longevity.

Dr. Nir Barzilai discusses genetics, lifestyle, and blood biomarkers influencing healthspan and lifespan, with a focus on targeting aging using metformin. The episode explores centenarians, factors affecting longevity, gender disparities in aging research, proteomic biomarkers, and future gerosarapeutic candidates. Actionable insights on personalized health strategies and the evolution of longevity medicine are shared.

Renowned longevity researcher Nir Barzilai discusses gerotherapeutics, antagonistic nutrients, metformin, longevity genes, aging hallmarks, mTOR, biological age testing, lifestyle interventions, mindset in aging, repurposing drugs, and why women have the aging advantage in this engaging podcast conversation.